跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Clavistan-625 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Clavistan-625
Approved
STANDARD
Clavistan-625
Flamingo Pharmaceuticals Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ea33528d3bd66d90
Company
Flamingo Pharmaceuticals Ltd.
Type
Standard
Approval Details
Approval Id
ea33528d3bd66d90
Drug Approval Philippines Name
Clavistan-625
Product Name
Clavistan-625
Registration Number
DRP-2159
Brand Name
Clavistan-625
Generic Name
Co-Amoxiclav
Dosage Form
Film-Coated Tablet
Dosage Strength
625mg
Manufacturer
Flamingo Pharmaceuticals Ltd.
Importer
Hexagon Pharmaceuticals
Issuance Date
28 March 2024
Expiry Date
22 June 2029
Pharmacologic Category
Antibacterial (Penicillin)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ea33528d3bd66d90
Type
Standard
Back to Philippines FDA Approvals